Health in Malaysia 1,083 indicators covering health for Malaysia. IndicatorLatest Year10-yr change Rank Suicide mortality rate, by sex 5.7 per 100,000 people 2021 up 29.5% 105th Share of deaths registered 97.84 2019 — 64th Prevalence of stunting, height for age 21.2% 2022 up 19.1% 44th Affordability - percentage of GDP per capita required to purchase 3.41 2022 up 13.7% 94th Road deaths over the long term 6,284 2018 down 6.8% 7th Japanese encephalitis - number of reported cases 18 2025 down 50.0% 7th Malaria cases reported 0 2024 down 100.0% 81st Deaths and missing persons due to natural disasters 15.6 2022 up 77,900.0% 20th Mean systolic blood pressure 122.5 2009 up 0.2% 135th Mean fasting blood glucose (mmol/l) 5.6 2009 up 1.8% 30th Number of pregnant women living with HIV who received antiretrovirals 207 2025 down 35.1% 62nd Hiv expenditure 20.80 million 2024 down 61.3% 48th Number of new leprosy cases with G2D among children 0 2024 — 35th Neonates protected at birth against neonatal tetanus (PAB) 95.0% 2022 up 5.6% 35th Prevalence of overweight, weight for height 5.6% 2022 down 21.1% 39th Most sold brand of cigarettes - price in currency reported 17.4 2020 up 74.0% 117th Most sold brand of cigarettes - taxes as a % of price - total tax 0.5% 2020 down 1.9% 104th Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.0% 2020 down 100.0% 109th Most sold brand of cigarettes - taxes as a % of price - import duties 0.0% 2020 — 33rd Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 — 41st Most sold brand of cigarettes - taxes as a % of price - value added 0.1% 2020 unchanged 149th Most sold brand of cigarettes - taxes as a % of price - specific 0.5% 2020 up 21.1% 26th Most sold brand of cigarettes - price in US$ at official exchange 4.1 2020 up 30.6% 68th Number healthy diet unaffordable 600,000 2024 down 57.1% 101st Import of environmentally sound technologies 14.16 billion 2020 up 18.5% 24th Most sold brand of cigarettes - price in PPP$ 11.13 2020 up 58.1% 26th Export of environmentally sound technologies 20.14 billion 2020 up 61.5% 13th Reported number of human rabies deaths 8 2024 — 27th Number of non-autochthonous leprosy cases 78 2024 down 8.2% 2nd Prevalence of wasting, weight for height, female 10.2% 2022 up 52.2% 9th Prevalence of wasting, weight for height, male 11.8% 2022 up 25.5% 7th Number reported cases of cholera 64 2021 down 89.1% 35th Prevalence of overweight, weight for height, female 4.5% 2022 down 30.8% 37th Prevalence of overweight, weight for height, male 6.6% 2022 down 14.3% 30th HPV immunization coverage estimates among primary target cohort (9-14) 81.0% 2025 down 1.2% 34th Prevalence of underweight, weight for age, female 14.8% 2022 up 27.6% 26th Prevalence of underweight, weight for age, male 15.9% 2022 up 19.5% 31st Prevalence of stunting, height for age, female 20.6% 2022 up 17.0% 38th Prevalence of stunting, height for age, male 21.8% 2022 up 21.1% 44th How many health warnings are approved by the law for cigarette 12 2022 up 100.0% 48th Tuberculosis - new and relapse cases 19,808 2011 up 33.6% 37th Number of reported cholera deaths 2 2019 up 100.0% 31st Physiotherapists 275 2024 up 100.7% 69th Pregnant women receiving prenatal care 97.2% 2014 up 32.1% 36th Coverage of the human papillomavirus vaccine 77 2024 down 9.4% 18th Percentage of principal display area mandated to be covered by health 55 2022 up 10.0% 76th Average of 13 International Health Regulations core capacity scores 100 2016 up 9.9% 1st New cases: pulmonary smear-negative 4,941 2012 down 2.4% 36th Estimated number of pregnant women living with HIV needing 500 2025 unchanged 57th Percentage of principal display area mandated to be covered by health 50 2022 up 25.0% 73rd Percentage of principal display area mandated to be covered by health 60 2022 unchanged 71st Average death rate due to natural disasters 95.18 2021 up 173,514.0% 11th Number of full-time equivalent staff in national agency 13 2022 up 160.0% 26th Total number of notified TB cases 24,711 2014 up 60.2% 34th The number of people with susceptibility test result for rifampicin 10,434 2021 — 20th Estimated number of pregnant women living with HIV 98 2025 up 21.0% 12th New cases: pulmonary smear unknown/not done 52 2012 — 73rd Smear-positive tuberculosis treatment-success rate 79.0% 2011 unchanged 106th Insufficiently active 86.17 2016 down 0.4% 38th The number of people with susceptibility test result for rifampicin 84.34 2021 — 86th ← Previous Page 17 of 19 Next →